QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

XNCR

QT54Xencor, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
12.64
-0.14-1.10%
OverviewShort InterestFilings
XNCRQT54Xencor, Inc.·NASDAQ
OverviewShort InterestFilings
12.64-1.10%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.29
Insider Own17.44%
Shs Outstand74.14M
Perf Week4.55%
Market Cap947.53MForward P/E-EPS next Y-3.27Insider Trans0.21%Shs Float-Perf Month21.42%
Enterprise Value1.11BPEG0.08EPS next Q-0.84Inst Own-Short Float-Perf Quarter4.29%
Income-169892057.00P/S9.73EPS this Y-69.55%Inst Trans-Short Ratio-Perf Half Y-23.63%
Sales97.36MP/B1.86EPS next Y15.67%ROA-23.40%Short Interest-Perf YTD-17.44%
Book/sh6.96P/C-EPS next 5Y-ROE-28.77%52W High18.69 -32.37%Perf Year52.11%
Cash/sh6.00P/FCF-EPS past 3/5Y-ROIC-30.58%52W Low6.92 82.66%Perf 3Y-
Dividend Est.-EV/EBITDA-8.42Sales past 3/5Y-8.60% 0.48%Gross Margin36.15%Volatility3.89% 3.48%Perf 5Y-
Dividend TTM-EV/Sales11.39EPS Y/Y TTM36.03%Oper. Margin-217.93%ATR (14)0.67Perf 10Y-
Dividend Ex-Date-Quick Ratio6.57Sales Y/Y TTM-10.91%Profit Margin-177.10%RSI (14)57.98Recom2.29
Dividend Gr. 3/5Y-Current Ratio6.57EPS Q/Q-159.09%SMA206.50%Beta1.59Target Price35.30
Payout0.00%Debt/Eq0.34Sales Q/Q-84.85%SMA503.95%Rel Volume2.36Prev Close12.78
Employees250LT Debt/Eq0.22EarningsAug 05SMA200-1.79%Avg Volume768.42KPrice12.64
IPO DateDec 03, 2013Option/ShortYes / YesEPS/Sales Surpr.-163.08% -82.14%Net Debt/EBITDA-1.22Volume1,815,287Change-1.10%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-24-26DowngradeJP MorganOverweight → Neutral
Dec-17-25ReiteratedBarclaysOverweight$23 → $26
Nov-24-25InitiatedTruistBuy$29
Nov-06-25ReiteratedCantor FitzgeraldOverweight$42
Oct-29-25UpgradeBarclaysUnderweight → Overweight$6.00 → $23
Oct-27-25ReiteratedRBC CapitalOutperform$31 → $18
Sep-16-25ReiteratedBarclaysUnderweight$6.00
Sep-03-25DowngradeB of A SecuritiesBuy → Neutral
Aug-07-25ReiteratedWedbushOutperform$31 → $26
Feb-28-25ReiteratedWedbushOutperform$38 → $31
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue98126110
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A6311228
Gross Profit36115-117
Selling, General and Administrative Excl. Other646459
Research and Development246239228
Other Operating Expense-63-10-226
Operating Income-213-178-178
Interest Expense283237
Unusual Expense
———
Non-Operating Income (Expense)-70-12020
Net Income Before Taxes-170-89-235
Income Taxes232
Consolidated Net Income-173-92-233
Net Income From Continuing Operations-173-92-237
Net Income-173-92-233
EPS (Recurring)-2.29-1.24-3.58
EPS (Basic, Before Extraordinaries)-2.29-1.24-3.58
EPS (Diluted)-2.29-1.24-3.58
EBITDA-131-47-186
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio9.678.99—
Gross Margin36.7391.27-106.36
Operating Margin-217.35-141.27-161.82
Net Margin-176.53-73.02-211.82
Shares Outstanding757465
Market Capitalization9481,133—
Operating Lease Expense
———
Insider Trading Volume
$13.29$11.95$10.62$9.28$7.94● Close Price0.00M0.74M1.48M2.21M2.95MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
GORMAN KEVIN CHARLESDirectorJun 15 '26Sale12.317,52792,65711,378Jun 17 12:00 AM
RANIERI RICHARD JDirectorJun 15 '26Sale12.315,47467,38513,709Jun 17 12:00 AM
GUSTAFSON KURT ADirectorJun 15 '26Sale12.315,47467,38514,709Jun 17 12:00 AM
Montgomery Alan BruceDirectorJun 15 '26Sale12.315,06462,33815,547Jun 17 12:00 AM
Cornelissen Bart JanSR. VICE PRESIDENT & CFOApr 10 '26Sale12.293,49942,99075,898Apr 13 12:00 AM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 06 '26Sale11.022,50227,571263,831Mar 09 12:00 AM
Dahiyat Bassil IPRESIDENT & CEOMar 06 '26Sale11.026,60672,796546,316Mar 09 12:00 AM
Eckert CeliaSVP, GENERAL COUNSELMar 06 '26Sale11.021,76719,47276,918Mar 09 12:00 AM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 05 '26Sale11.254,11846,309266,333Mar 09 12:00 AM
Dahiyat Bassil IPRESIDENT & CEOMar 05 '26Sale11.2514,870167,221552,922Mar 09 12:00 AM
Cornelissen Bart JanSR. VICE PRESIDENT & CFOMar 05 '26Sale11.252,51728,30579,397Mar 09 12:00 AM
Eckert CeliaSVP, GENERAL COUNSELMar 05 '26Sale11.253,24436,48078,685Mar 09 12:00 AM
Dahiyat Bassil IPRESIDENT & CEOMar 03 '26Sale11.906,75880,387567,792Mar 04 12:00 AM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 03 '26Sale11.902,66331,677270,451Mar 04 12:00 AM
Eckert CeliaSVP, GENERAL COUNSELMar 03 '26Sale11.901,49217,74781,929Mar 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR